Daniella Turenshine, CFO of the company, sold 14,575 stock shares in a single transaction on June 15th. The shares were purchased at $8.44 on average, resulting in a transaction totaling $123,013.00. The chief financial officer owns 440 201 shares of the company valued at $3 715 296.44. This link
Daniella Turenshine made the following recent trades:
Daniella Turenshine, on Friday, 2nd June, sold 13,557 FIGS shares. The shares were sold for an average price $8.34. This totaled $113,065.38.
On Thursday, the stock rose $0.11 to $8.53. The stock traded 1,814,039 compared to the average of 3,270.843. The market cap is $1.42 Billion, the PE ratio is 106.56 and PEG ratio 14.23, with a beta value of 1.49. FIGS Inc.'s low for the past 12 months is $5.55, and its high for that same period is $13.75. The company has a moving average of $7.59 for the last fifty days and $7.55 for the past two hundred days.
The company last announced its results on Thursday 4th May. The company's $0.01 per share earnings for the quarter exceeded analysts' expectations of ($0.01), by $0.02. Revenue for the quarter was $120.23 million, which is higher than analyst expectations of $112.65. FIGS's net margin was 2.75%, and its return on equity was 7.06%. Revenue was up 9.2% year-over-year. In the same quarter of the prior year, the company earned $0.05 in EPS. Analysts expect FIGS, Inc. to post 0.06 EPS in the current fiscal year.
Wall Street analysts weigh in
Recently, several equity analysts commented on FIGS's shares. Roth Mkm began coverage of FIGS shares in a report published on Wednesday, 3rd May. The stock was given a buy' rating with a price target of $9.00. Credit Suisse Group reduced their price target on shares of FIGS to $10 and gave the company an "outperform" rating in a report published on March 1st. Telsey Advisory Group reduced their price target on shares of FIGS to $11.00 from $12.00 in a report published on March 1st. Oppenheimer reduced their price target on shares of FIGS by $9.00 from $12.00 and gave the company an 'outperform rating' in a report published on Tuesday, 21st March. Barclays lowered the rating of FIGS shares from 'equal' to 'underweight" in a report published on May 2nd. Two analysts gave the stock a sell recommendation, three a hold recommendation and six a buy recommendation. According to MarketBeat.com FIGS currently has a consensus of 'Hold,' with an average price of $8.94.
Inflows of Institutional Capital and Outflows
Several large investors recently changed their stock positions. Atria Wealth Solutions Inc. purchased a new position of FIGS shares during the first quarter, valued at approximately $270,000. Ameriprise Financial Inc. increased its position in FIGS in the first quarter by 62.2%. Ameriprise Financial Inc. owns now 549,854 of the company’s stock valued at $3,404,000, after buying an additional 210.862 shares during the last quarter. JPMorgan Chase & Co. increased its stake in FIGS during the first quarter by 171.1%. JPMorgan Chase & Co. owns 354,503 of the company stock, worth $2.194,000. This is after buying an additional 223,740 during the period. Front Street Capital Management Inc. purchased a new FIGS position during the first quarter, worth approximately $66,000. Prentice Capital Management LP also bought a new FIGS position during the first three months worth approximately $2,033,000.
FIGS Company Profile
FIGS, Inc is a direct-to consumer healthcare apparel and lifestyle business in the United States. It designs and markets healthcare apparel, including lab coats and under scrubs. Other products include activewear, loungewear and compression socks. The company also sells sports bras and tops. It also has performance leggings.
MarketBeat.com offers a FREE daily email newsletter